{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:53:02Z","timestamp":1783947182377,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,15]]},"DOI":"10.7759\/cureus.99264","type":"journal-article","created":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:03:27Z","timestamp":1765803807000},"source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of Intravenous Ketamine in Status Epilepticus: A Systematic Review and Meta-Analysis With Pediatric Subgroup Analysis"],"prefix":"10.7759","author":[{"given":"Bader F","family":"Aldhafeeri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Alkhaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Alajmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lolwah","family":"Alenezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumoukh","family":"Alajmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esra","family":"Alenezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouq","family":"Almotawtah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah Mohammed","family":"Alenezi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahraa","family":"Alnakkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jassim","family":"Alqallaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fajer","family":"Altammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1590\/0004-282X-ANP-2022-S113","article-title":"Status epilepticus: review on diagnosis, monitoring and treatment","volume":"80","author":"Pinto LF","year":"2022","unstructured":"Pinto LF, Oliveira JP, Midon AM. Status epilepticus: review on diagnosis, monitoring and treatment. Arq Neuropsiquiatr. 2022, 80:193-203. 10.1590\/0004-282X-ANP-2022-S113","journal-title":"Arq Neuropsiquiatr"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70187-9","article-title":"Management of refractory status epilepticus in adults: still more questions than answers","volume":"10","author":"Rossetti AO","year":"2011","unstructured":"Rossetti AO, Lowenstein DH. Management of refractory status epilepticus in adults: still more questions than answers. Lancet Neurol. 2011, 10:922-30. 10.1016\/S1474-4422(11)70187-9","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1212\/CPJ.0000000000200520","article-title":"Super-refractory status epilepticus diagnosis, management, and prognostication: an international survey study","volume":"15","author":"Woodward MR","year":"2025","unstructured":"Woodward MR, Brown JP, Kittner SJ, Badjatia N, Gilmore EJ, Johnson EL, Morris NA. Super-refractory status epilepticus diagnosis, management, and prognostication: an international survey study. Neurol Clin Pract. 2025, 15:200520. 10.1212\/CPJ.0000000000200520","journal-title":"Neurol Clin Pract"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-018-0640-5","article-title":"Treatment of refractory and super-refractory status epilepticus","volume":"15","author":"Rai S","year":"2018","unstructured":"Rai S, Drislane FW. Treatment of refractory and super-refractory status epilepticus. Neurotherapeutics. 2018, 15:697-712. 10.1007\/s13311-018-0640-5","journal-title":"Neurotherapeutics"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2013.04.015","article-title":"Molecular mechanisms of antiseizure drug activity at GABAA receptors","volume":"22","author":"Greenfield LJ Jr","year":"2013","unstructured":"Greenfield LJ Jr. Molecular mechanisms of antiseizure drug activity at GABAA receptors. Seizure. 2013, 22:589-600. 10.1016\/j.seizure.2013.04.015","journal-title":"Seizure"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/med\/9780197549469.003.0048","article-title":"GABAA receptors, seizures, and epilepsy","author":"Olsen RW","year":"2024","unstructured":"Olsen RW, Wallner M, Rogawski MA. GABAA receptors, seizures, and epilepsy. Jasper\u2019s Basic Mechanisms of the Epilepsies. Noebels JL, Avoli M, Rogawski MA, Vezzani A, Delgado-Escueta AV (ed): Oxford University Press, New York; 2024. 1025-46. 10.1093\/med\/9780197549469.003.0048"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.amj.2023.09.011","article-title":"Ketamine efficacy for management of status epilepticus: considerations for prehospital clinicians","volume":"43","author":"Williams NC","year":"2024","unstructured":"Williams NC, Morgan LA, Friedman J, Siegler J. Ketamine efficacy for management of status epilepticus: considerations for prehospital clinicians. Air Med J. 2024, 43:84-9. 10.1016\/j.amj.2023.09.011","journal-title":"Air Med J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2015.05.010","article-title":"Ketamine for the treatment of refractory status epilepticus","volume":"30","author":"Fang Y","year":"2015","unstructured":"Fang Y, Wang X. Ketamine for the treatment of refractory status epilepticus. Seizure. 2015, 30:14-20. 10.1016\/j.seizure.2015.05.010","journal-title":"Seizure"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2024.01.013","article-title":"Ketamine in the treatment of refractory and super-refractory status epilepticus: experience from two centres","volume":"117","author":"Garc\u00eda-Ruiz M","year":"2024","unstructured":"Garc\u00eda-Ruiz M, Rodr\u00edguez PM, Palliotti L, et al.. Ketamine in the treatment of refractory and super-refractory status epilepticus: experience from two centres. Seizure. 2024, 117:13-9. 10.1016\/j.seizure.2024.01.013","journal-title":"Seizure"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s40263-016-0371-2","article-title":"(S)-ketamine in refractory and super-refractory status epilepticus: a retrospective study","volume":"30","author":"H\u00f6fler J","year":"2016","unstructured":"H\u00f6fler J, Rohracher A, Kalss G, et al.. (S)-ketamine in refractory and super-refractory status epilepticus: a retrospective study. CNS Drugs. 2016, 30:869-76. 10.1007\/s40263-016-0371-2","journal-title":"CNS Drugs"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010611","article-title":"Ketamine to treat super-refractory status epilepticus","volume":"95","author":"Alkhachroum A","year":"2020","unstructured":"Alkhachroum A, Der-Nigoghossian CA, Mathews E, et al.. Ketamine to treat super-refractory status epilepticus. Neurology. 2020, 95:2286-94. 10.1212\/WNL.0000000000010611","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13610","article-title":"Ketamine in adult super-refractory status epilepticus: efficacy analysis on a prospective registry","volume":"145","author":"Caranzano L","year":"2022","unstructured":"Caranzano L, Novy J, Rossetti AO. Ketamine in adult super-refractory status epilepticus: efficacy analysis on a prospective registry. Acta Neurol Scand. 2022, 145:737-42. 10.1111\/ane.13610","journal-title":"Acta Neurol Scand"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12247","article-title":"Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study","volume":"54","author":"Gaspard N","year":"2013","unstructured":"Gaspard N, Foreman B, Judd LM, et al.. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia. 2013, 54:1498-503. 10.1111\/epi.12247","journal-title":"Epilepsia"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2013.01.007","article-title":"Ketamine use in the treatment of refractory status epilepticus","volume":"105","author":"Synowiec AS","year":"2013","unstructured":"Synowiec AS, Singh DS, Yenugadhati V, Valeriano JP, Schramke CJ, Kelly KM. Ketamine use in the treatment of refractory status epilepticus. Epilepsy Res. 2013, 105:183-8. 10.1016\/j.eplepsyres.2013.01.007","journal-title":"Epilepsy Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200889","article-title":"Ketamine for management of neonatal and pediatric refractory status epilepticus","volume":"99","author":"Jacobwitz M","year":"2022","unstructured":"Jacobwitz M, Mulvihill C, Kaufman MC, et al.. Ketamine for management of neonatal and pediatric refractory status epilepticus. Neurology. 2022, 99:1227-38. 10.1212\/WNL.0000000000200889","journal-title":"Neurology"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-023-01859-2","article-title":"A comparison of ketamine and midazolam as first-line anesthetic infusions for pediatric status epilepticus","volume":"40","author":"Jacobwitz M","year":"2024","unstructured":"Jacobwitz M, Mulvihill C, Kaufman MC, et al.. A comparison of ketamine and midazolam as first-line anesthetic infusions for pediatric status epilepticus. Neurocrit Care. 2024, 40:984-95. 10.1007\/s12028-023-01859-2","journal-title":"Neurocrit Care"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2024.122950","article-title":"Efficacy and safety of ketamine for pediatric and adolescent super-refractory status epilepticus and the effect of cerebral inflammatory conditions","volume":"459","author":"Kuki I","year":"2024","unstructured":"Kuki I, Inoue T, Fukuoka M, et al.. Efficacy and safety of ketamine for pediatric and adolescent super-refractory status epilepticus and the effect of cerebral inflammatory conditions. J Neurol Sci. 2024, 459:122950. 10.1016\/j.jns.2024.122950","journal-title":"J Neurol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2015.06.019","article-title":"Ketamine in refractory convulsive status epilepticus in children avoids endotracheal intubation","volume":"49","author":"Ilvento L","year":"2015","unstructured":"Ilvento L, Rosati A, Marini C, L'Erario M, Mirabile L, Guerrini R. Ketamine in refractory convulsive status epilepticus in children avoids endotracheal intubation. Epilepsy Behav. 2015, 49:343-6. 10.1016\/j.yebeh.2015.06.019","journal-title":"Epilepsy Behav"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12453-7","article-title":"The efficacy and safety of ketamine in the treatment of super-refractory status epilepticus: a systematic review","volume":"271","author":"Yan M","year":"2024","unstructured":"Yan M, Sun T, Liu J, Chang Q. The efficacy and safety of ketamine in the treatment of super-refractory status epilepticus: a systematic review. J Neurol. 2024, 271:3942-52. 10.1007\/s00415-024-12453-7","journal-title":"J Neurol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/15357597231171240","article-title":"Midazolam, ketamine, and propofol: while we slept, others worked on anesthetizing infusions for refractory status epilepticus","volume":"23","author":"Vossler DG","year":"2023","unstructured":"Vossler DG. Midazolam, ketamine, and propofol: while we slept, others worked on anesthetizing infusions for refractory status epilepticus. Epilepsy Curr. 2023, 23:230-2. 10.1177\/15357597231171240","journal-title":"Epilepsy Curr"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-53360-6","article-title":"Association of ketamine use with lower risks of post-intubation hypotension in hemodynamically-unstable patients in the emergency department","volume":"9","author":"Ishimaru T","year":"2019","unstructured":"Ishimaru T, Goto T, Takahashi J, Okamoto H, Hagiwara Y, Watase H, Hasegawa K. Association of ketamine use with lower risks of post-intubation hypotension in hemodynamically-unstable patients in the emergency department. Sci Rep. 2019, 9:17230. 10.1038\/s41598-019-53360-6","journal-title":"Sci Rep"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/epi.12037","article-title":"Possible alterations in GABAA receptor signaling that underlie benzodiazepine-resistant seizures","volume":"53","author":"Deeb TZ","year":"2012","unstructured":"Deeb TZ, Maguire J, Moss SJ. Possible alterations in GABAA receptor signaling that underlie benzodiazepine-resistant seizures. Epilepsia. 2012, 53:79-88. 10.1111\/epi.12037","journal-title":"Epilepsia"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2021.797253","article-title":"Roles of N-methyl-D-aspartate receptors (NMDARs) in epilepsy","volume":"14","author":"Chen S","year":"2021","unstructured":"Chen S, Xu D, Fan L, Fang Z, Wang X, Li M. Roles of N-methyl-D-aspartate receptors (NMDARs) in epilepsy. Front Mol Neurosci. 2021, 14:797253. 10.3389\/fnmol.2021.797253","journal-title":"Front Mol Neurosci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1228895","article-title":"Recent advances in the study of anesthesia-and analgesia-related mechanisms of S-ketamine","volume":"14","author":"Zhou JS","year":"2023","unstructured":"Zhou JS, Peng GF, Liang WD, et al.. Recent advances in the study of anesthesia-and analgesia-related mechanisms of S-ketamine. Front Pharmacol. 2023, 14:1228895. 10.3389\/fphar.2023.1228895","journal-title":"Front Pharmacol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199805000-00034","article-title":"Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens","volume":"26","author":"Shafer A","year":"1998","unstructured":"Shafer A. Complications of sedation with midazolam in the intensive care unit and a comparison with other sedative regimens. Crit Care Med. 1998, 26:947-56. 10.1097\/00003246-199805000-00034","journal-title":"Crit Care Med"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aws091","article-title":"The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy","volume":"135","author":"Ferlisi M","year":"2012","unstructured":"Ferlisi M, Shorvon S. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain. 2012, 135:2314-28. 10.1093\/brain\/aws091","journal-title":"Brain"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2022.154098","article-title":"The incidence of propofol infusion syndrome in critically-ill patients","volume":"71","author":"Li WK","year":"2022","unstructured":"Li WK, Chen XJ, Altshuler D, Islam S, Spiegler P, Emerson L, Bender M. The incidence of propofol infusion syndrome in critically-ill patients. J Crit Care. 2022, 71:154098. 10.1016\/j.jcrc.2022.154098","journal-title":"J Crit Care"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1177\/10600280211051028","article-title":"Hemodynamic effects of ketamine compared with propofol or dexmedetomidine as continuous ICU sedation","volume":"56","author":"Atchley E","year":"2022","unstructured":"Atchley E, Tesoro E, Meyer R, Bauer A, Pulver M, Benken S. Hemodynamic effects of ketamine compared with propofol or dexmedetomidine as continuous ICU sedation. Ann Pharmacother. 2022, 56:764-72. 10.1177\/10600280211051028","journal-title":"Ann Pharmacother"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/0310057X1804600514","article-title":"Potential consequences of high-dose infusion of ketamine for refractory status epilepticus: case reports and systematic literature review","volume":"46","author":"Golub D","year":"2018","unstructured":"Golub D, Yanai A, Darzi K, Papadopoulos J, Kaufman B. Potential consequences of high-dose infusion of ketamine for refractory status epilepticus: case reports and systematic literature review. Anaesth Intensive Care. 2018, 46:516-28. 10.1177\/0310057X1804600514","journal-title":"Anaesth Intensive Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/445354-efficacy-of-intravenous-ketamine-in-status-epilepticus-a-systematic-review-and-meta-analysis-with-pediatric-subgroup-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T13:03:29Z","timestamp":1765803809000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/445354-efficacy-of-intravenous-ketamine-in-status-epilepticus-a-systematic-review-and-meta-analysis-with-pediatric-subgroup-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,15]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.99264","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,15]]}}}